These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6125955)

  • 1. Immobilized and insolubilized drugs, hormones, and neurotransmitters: properties, mechanisms of action and applications.
    Venter JC
    Pharmacol Rev; 1982 Jun; 34(2):153-87. PubMed ID: 6125955
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of brain slices in central nervous system pharmacology.
    Dunwiddie T; Mueller A; Basile A
    Fed Proc; 1983 Sep; 42(12):2891-8. PubMed ID: 6136423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-subsite receptors for multivalent ligands. Application to drugs, hormones, and neurotransmitters.
    De Lean A; Munson PJ; Rodbard D
    Mol Pharmacol; 1979 Jan; 15(1):60-70. PubMed ID: 34090
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of dissolution-controlled solute release from porous drug delivery polymeric systems.
    Peppas NA
    J Biomed Mater Res; 1983 Nov; 17(6):1079-87. PubMed ID: 6654927
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
    Loftsson T
    Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action mechanism of the thyroid hormone in the heart cell--interaction of the thyroid hormone and catecholamines].
    Will-Shahab L
    Z Gesamte Inn Med; 1980 May; 35(10):393-5. PubMed ID: 6254282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of receptor regulation during repeated administration of drugs].
    Montastruc JL; Galitzky J; Berlan M; Montastruc P
    Therapie; 1993; 48(5):421-6. PubMed ID: 8146818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.
    Jaspart S; Piel G; Delattre L; Evrard B
    Expert Opin Drug Deliv; 2005 Jan; 2(1):75-87. PubMed ID: 16296736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agmatine--an endogenous ligand of imidazoline receptors].
    Kozaeva LP; Korobov NV
    Eksp Klin Farmakol; 2003; 66(5):69-73. PubMed ID: 14650220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic dosage and physicochemical constants or bases and acids].
    Volpi A; Toffoli F
    Boll Chim Farm; 1979 Oct; 118(10):594-609. PubMed ID: 553526
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of peptide hormones and adrenergic agents on membrane potentials of target cells.
    Zierler K; Rogus EM
    Fed Proc; 1981 Feb; 40(2):121-4. PubMed ID: 7007082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation.
    Mulder AH; Tack CJ; Olthaar AJ; Smits P; Sweep FC; Bosch RR
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E627-33. PubMed ID: 15914506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of the properties of drugs combined with polymers. II].
    Virnik AD; Snezhko VA; Khomiakov KP
    Polim Med; 1977; 7(1):27-55. PubMed ID: 887524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in drug design].
    Guo ZR
    Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):238-44. PubMed ID: 6393337
    [No Abstract]   [Full Text] [Related]  

  • 20. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.